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POINT-OF-CARE ECHOCARDIOGRAPHY AND ELECTROCARDIOGRAPHY IN
ASSESSING SUSPECTED PULMONARY EMBLOSIM.
John Grotberg, James Daley, Richard A. Taylor, Chris L. Moore. Section of Ultrasound,
Department of Emergency Medicine, Yale University, School of Medicine, New
Haven, CT.
Daniels and TwiST electrocardiogram (ECG) scores have been proposed to
detect right heart strain (RHS). Tricuspid Annular Plane Systolic Excursion (TAPSE)
is a reliable indicator of RHS in patients with acute pulmonary embolism (PE). I
aimed to investigate the relationship between these ECG scores, TAPSE, and the
level of care required for patients with acute PE. This was a prospective
observational study of 110 patients undergoing CTA for suspected PE. ECGs were
obtained and patients underwent bedside echocardiography. Low TAPSE was
defined as ≤17 mm. Mean Daniels and TwiST scores were compared to mean TAPSE,
and all were used to evaluate the risk of requiring “PE elevated care” (PEEC),
defined as care more aggressive than simple heparination. Mean Daniels and TwiST
scores were significantly different between low and high TAPSE groups (p<0.0001),
and high Daniels and TwiST scores correlated to low TAPSE (p<0.0001, p=0.0002).
PE positive (PE+) patients had lower mean TAPSE than PE negative (PE-) patients
(p=0.0003). PE+ patients had a higher mean Daniels score and mean TwiST score
than PE- patients (p=0.0024, p=0.0033). Patients requiring PEEC had lower mean
TAPSE (p=0.047) and higher mean TwiST (p=0.020) values. TAPSE ≤17 mm and
TwiST ≥5 had increased risks of 6.9 (p=0.045) and 4.4 (p=0.025) respectively for
requiring PEEC. Both the Daniels and TwiST ECG scores correlated with TAPSE. All
three were predictive of PE on CTA, while TAPSE and TwiST were predictive of
requiring PEEC, suggesting their prognostic value in PE care.
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1. Introduction
1.1 Deep Venous Thrombosis and Pulmonary Embolism
1.1.1 Background
Venous thromboembolism (VTE), encompassing both deep venous thrombosis
(DVT) and pulmonary embolism (PE), is one of the three leading cardiovascular
causes of death, with the other two leading causes being myocardial infarction (MI)
and stroke. It is estimated that between 100,000 and 300,000 VTE-related deaths
occur annually in the United States. Approximately 75% of symptomatic VTE events
are community-acquired, while the remaining 25% are hospital acquired, making
the recognition and treatment of VTE essential in both emergency medicine and
critical care settings (1). In 1999, the International Cooperative Pulmonary
Embolism Registry (ICOPER) examined 2454 consecutive eligible patients with
acute PE from 52 hospitals in 7 countries, analyzing all-cause mortalities within 3
months of diagnosis. The overall crude 3-month mortality rate was 17.4%, of which
45.1% were ascribed to PE. In addition, significant prognostic factors included age
over 70 years old, cancer, congestive heart failure (CHF), chronic obstructive
pulmonary disease (COPD), systolic arterial hypotension, tachypnea, and right
ventricular (RV) hypokinesis on echocardiography (2). Due to the variety of ways
patients can present with acute PE, and its often, deadly prognosis, it is often
referred to as a great masquerader. It is for this reason that so much research has
focused on understanding the pathophysiology, attaining better diagnostic inclusion
and exclusion criteria, and determining prognostic factors for risk stratification and
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therapy. The bedrock of research in diagnosing acute pulmonary embolism
surrounds methods to increase the sensitivity of diagnostic criteria, while also
avoiding unnecessary radiation with CT scans, while also incorporating methods to
properly stratify patients who may have increased morbidity and mortality.
1.1.2 Pathophysiology
Acute PE has physiological consequences of interfering with both circulation
and gas exchange. Gas exchange is disrupted due to inflammatory mediators,
resulting in surfactant dysfunction, atelectasis and intrapulmonary shunting along
with increased dead space ventilation and V/Q mismatch (3,4), while circulatory
changes occur due to mechanical obstruction from the thrombus (or thrombi), as
well as PE-induced vasoconstriction from inflammatory mediators and hypoxia,
leading to increased pulmonary arterial pressures and vascular resistance (4). Acute
increases in pulmonary vascular resistance cause strain on the right side of the
heart secondary to the increased pressure required to maintain right-sided cardiac
output. Increased pressures in the RV and right atrium leading to RV dilation and
systolic dysfunction of the myocardium. As RV contraction time becomes prolonged,
bowing of the interventricular septum can result (5), leading to decreased LV filling
and decreased cardiac output and cardiac index (CI). Additionally, development of a
right bundle branch block (RBBB) can occur secondary to increased pressure on the
subendocardial conduction system as well as decreased right coronary perfusion
pressure. This can exacerbate the desynchronization of the ventricles, leading to
decreased LV filling and hypotension (6). An increase in demand can also lead to RV
ischemia (4). The aforementioned pathophysiology can result in a fatal feedback
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loop of increased RV pressure and RV dilation, decreased cardiac output, decreased
coronary perfusion pressure and increased RV myocardial ischemia, leading to
acute RV failure.
1.1.3 Diagnostic Evaluation
In analyzing the current standards for diagnostic evaluation of patients with
suspected PE, it is necessary to begin with the history and physical exam. Even
before any serologic testing or imaging, patients can be risk stratified for acute PE
with PE Rule-Out Criteria (PERC). In particular, PERC coupled with physician gestalt
for PE has shown to be a highly sensitive test. The components of the PERC criteria
involve the following eight questions (7):
1.
2.
3.
4.
5.
6.
7.

Is the patient older than 49 years of age?
Is the pulse rate above 99 beats per minute?
Is the pulse oximetry reading > 95% while the patient breathes room air?
Is there a present history of hemoptysis?
Is the patient taking exogenous estrogen?
Does the patient have a prior diagnosis of venous thromboembolism (VTE)?
Has the patient had recent surgery or trauma (Requiring endotracheal
intubation or hospitalization in the previous 4 weeks)?
8. Does the patient have unilateral leg swelling?
In 2008, a large study incorporating more than 8,000 patients across 13
emergency departments evaluated PERC. Among low gestalt suspicion and PERC (-)
(answering no to the 8 PERC questions), 15 patients were VTE (+) and one patient
died, yielding a false negative rate of 1%. As a diagnostic test, low suspicion and
PERC (-) had a sensitivity of 97.4% and a specificity of 21.9% (8), allowing exclusion
of PE without D-dimer testing that could lead to unnecessary imaging. Avoiding
unnecessary imaging and radiation is an endeavor that has been investigated, and is
one that point of care ultrasound can also play a role in risk stratification. In 2012,
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the National Quality Forum (NQF) endorsed a performance measure to increase
imaging efficiency for evaluation of PE in the ED. The primary outcome was the
proportion of imaging that was potentially avoidable according to the NQF measure,
as defined by imaging a patient with low pretest probability for PE who either did
not have a D-dimer test ordered, or who had a negative D-dimer test result. It was
found that one third of imaging could be categorized as avoidable (9). Apart from
PERC, additional criteria may include presence of limb, whole-body, or neurologic
immobility. Contrary to belief, travel greater than 8 hours was not shown to
significantly increase the risk for VTE (10). It should be noted that other scoring
systems exist to aid physicians in gestalt for suspecting PE. Notably, the two most
commonly used scoring systems are the Wells PE Criteria, as well as the Geneva
Score (1). Both scoring systems aid in risk stratifying patients and guiding the need
for further diagnostic work up. They overlap in many respects, including aspects of
patient history such as age, history of prior DVT/PE, recent surgery and active
malignancy (1).
While the use of ECG and bedside echo will be discussed further as diagnostic
and prognostic tools in patients with suspected PE, it is also worth briefly discussing
the value of laboratory tests. Many laboratory tests also aid in the diagnostic work
up of patients with suspected PE, and include troponin, B-type natriuretic peptide,
and D-Dimer (11). However, these tests alone can be elevated in other pathologies,
and must therefore be added to the entirety of the clinical context surrounding a
patient. For example, Kabrhel et al. found that significant positive predictors of
elevated D-Dimer in patients evaluated for PE included female sex, increasing age,
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black (vs. white) race, cocaine use, neurologic immobility, prior venous
thromboembolism, hemoptysis, hemodialysis, active malignancy, and numerous
others. On the other hand, several variables known to be associated with PE were
not significantly associated with a positive D-Dimer, such as BMI, exogenous
estrogen use, thrombophilia, trauma within 4 weeks, and others (12).
1.2 Management of Acute Pulmonary Embolism
1.2.1 Prevention
Naturally preventing PE is an important endeavor. It is critical in reducing
the death rate, morbidity, and financial cost of PE. Mechanical measures and
pharmacological measures currently exist to aid in its prevention. Mechanical
measures include compression stockings, intermittent pneumatic compression
devices and placement of temporary or permanent inferior vena cava (IVC) filters.
Pharmacological measures include fractionated heparin, low-molecular-weight
heparin, warfarin, and fondaparinux (11).
1.2.2 Anticoagulation vs. Thrombolysis
When discussing management of acute PE, it should be mentioned that 3
subtypes exist that depend on certain clinical and/or diagnostic criteria. Massive PE
is defined as PE with sustained hypotension (systolic blood pressure < 90 for more
than 15 minutes) not due to another cause other than the PE (1). Submassive PE is
defined as PE without hypotension, but with evidence of RV dysfunction or
myocardial necrosis. This can be evidenced by RV dilation or dysfunction by
echocardiography, CT, elevated troponin, elevated BNP, or ECG changes consistent
with right heart strain (1). Low risk PE refers to those PEs that do not produce
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hypotension or evidence of right heart strain (1). In low risk and submassive PE, the
common treatment is heparin-based anticoagulation by continuous infusion with a
target partial thromboplastin time of 60-80 seconds, however it is also becoming
common for these patients to be treated with Novel Oral Anticoagulants (NOACs)
such as rivaroxaban and apixaban, or bivalirudin for patients with heparin-induced
thrombocytopenia (HIT), while patients with massive PE often receive thrombolysis
by recombinant tissue plasminogen activator (tPA) as 100 mg continuously infused
over a 2 hour period (11). However, controversy remains about how to treat
patients with submassive PE who are normotensive. In a double-blinded study
conducted in 49 centers in Germany by the Management Strategies and Prognosis of
Pulmonary Embolism Trial-3 (MAPPET-3), normotensive patients with acute PE
were randomly treated with tPA (after excluding bleeding risk) and heparin or
placebo and heparin. The primary endpoint examined included death or clinical
deterioration. The incidence of primary endpoint was significantly higher in the
placebo and heparin group compared to tPA and heparin and the probability of 30day event free survival was significantly higher in the tPA and heparin group (13).
This data echoed earlier data from Goldhaber et al. (14), and has since been
discussed in case reports (15,16), in which patients who received tPA had a more
rapid reversal of RV dysfunction, and experienced no recurrence of clinical episodes
of PE compared to 5 recurrences and 2 deaths in the heparin-alone group.
The rapid improvement and lower incidence of adverse clinical outcomes of
patients who received tPA raises the importance of acquiring new methods of risk
stratification for emergency department physicians. Identifying the subset of
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patients with submassive PE and prognostic indication for poor clinical outcome
may aid in driving therapy with tPA if they are low risk for bleeding. While
continued research must be performed in the risk for bleeding of patients with acute
PE, a study of 104 patients at Brigham and Women’s Hospital with acute PE who
received tPA was performed, and major bleeding was found in 19.2% of patients.
The principal site of bleeding was unknown (45%), while other sites included GI,
retroperitoneal, splenic, and intracranial (5%). It was also determined that
independent predictors for major bleeding were administration of catecholamines
for systemic arterial hypotension, cancer, diabetes mellitus, and elevated
international normalized ratio (INR) prior to fibrinolysis (17). These relatively high
rates of spontaneous bleeding may have occurred due to many factors, namely the
increased average INR in patients who had high risk bleeding events compared to
those who did not (1.4 vs 1.1), as well as the small sample size (only 1 patient had
an intracranial hemorrhage, which represented 5% of the patients who had a major
bleeding event) (17). More recent literature has evaluated whether the dose of 100
mg tPA as a continuous infusion may be increasing the bleeding risk, and has sought
to elucidate whether lower doses of tPA can both improve RV function and mortality
while also minimizing the risk of spontaneous hemorrhage in patients with
submassive PE. A meta-analysis by Zhang et al. showed that decreased doses of tPA
(0.6 mg/kg bolus followed by 50 mg/2h) in patients with acute PE was non-inferior
in achieving hemodynamic improvement when compared to standard doses of tPA
(100 mg), while also yielding a decreased bleeding risk compared to standard tPA
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dosing, as well as showing no increased risk in bleeding when compared to heparin
alone (18).
1.2.3 Invasive Therapies for Acute Pulmonary Embolism
It should be noted that for patients with contraindications to thrombolysis,
catheter-based or surgical embolectomy can be considered if risk stratification
indicates a high probability of poor outcome leading to loss of hemodynamic
stability (11). The prognosis for open embolectomy has dramatically improved.
During its renaissance, newer surgical techniques led to an 89% survival rate of 29
embolectomies performed at Brigham and Women’s Hospital within a 2-year period
(11). Other invasive strategies include catheter-mediated thrombus fragmentation,
rheolytic thrombectomy, catheter-mediated thromboembolus aspiration, and
catheter-directed thrombolysis via infusion catheters such as the Endo Wave
System (EKOS) (19). Catheter directed thrombolysis has been shown to improve RV
function by reducing pulmonary arterial pressures as well as RV pressures while
decreasing the risk of adverse bleeding when compared to systemic thrombolysis
(19).
1.2.4 Inhaled Nitric Oxide
As previously mentioned, acute PE increases pulmonary arterial resistance,
and can lead to right ventricular failure and circulatory collapse. Inhaled nitric oxide
(NO) leads to immediate vasodilation of the pulmonary circulation. Inhaled NO is
selective to the pulmonary circulation due to its rapid binding and inactivation by
hemoglobin. Thus, systemic circulation does not experience vasodilation (20). Thus
far, there have been no randomized controlled trials evaluating the effect of inhaled
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NO on patients with massive and submassive PE. However, numerous case studies
have shown it holds promise, in particular with patients for which tPA may be
contraindicated (20-22). For example, Szold et al. found that in four patients
suffering from acute massive PE after having abdominal surgery, inhaled NO (20-25
ppm), led an improvement in pulmonary and systemic blood pressures, heart rate
and lung gas exchange within minutes after administration (20).
1.3 Tricuspid Annular Plane Systolic Excursion (TAPSE)
1.3.1 Assessment of Right Ventricular Systolic Function
There are several direct and surrogate measures of right heart strain in acute
PE, but the quantitative measurement of tricuspid annular plane systolic excursion
(TAPSE) has been found to be reproducible and to provide prognostic value in both
PE and other disorders. The determination of TAPSE by bedside echo in the
Emergency Department has been less well investigated. Due to the limited access to
cardiology consults at some hospitals, or due to the amount of time it may take for a
consult, early risk stratification by emergency physicians for patients with acute PE
may help guide appropriate therapy and prognosis.
The ability to assess RV systolic function in an Emergency Department
setting is critical in aiding in the formulation of a diagnosis for patients with
undifferentiated dyspnea or pleuritic chest pain, as well as for directing therapy. As
previously mentioned, the presence of RV systolic dysfunction is a major indication
for thrombolytic therapy and a prognostic indicator in patients with massive or
submassive PE (23). 2D echocardiography provides a unique tool that emergency
physicians can use at the bedside to assess RV function and acute right heart strain.
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Many 2D echocardiography assessments of RV strain, and more specifically RV
strain in acute PE, are qualitative in nature, and include RV size compared to LV size,
septal flattening, tricuspid regurgitation with color flow Doppler, paradoxical septal
motion, diastolic left ventricular (LV) impairment, direct visualization of PE, right
ventricular hypertrophy (RVH), a qualitatively plethoric inferior vena cava (IVC),
and McConnell’s sign (RV free wall hypokinesis with apical sparing) (23-25). In
particular, the apical sparing of McConnell’s sign has been explained by mechanical
tethering of the RV apex to a hyperdynamic left ventricle (24,25). However,
cardiologists have sought more quantitative measurements to estimate RV systolic
function, many of which have not permeated emergency medicine research and
clinical practice.
One such measurement is that of tricuspid annular plane systolic excursion,
or TAPSE. The right side of the heart, unlike the left side, contracts along the
longitudinal axis of the heart due to the longitudinal direction of RV muscle fibers.
This can be visualized on transthoracic echocardiogram (TTE) as the base of the
heart ascends toward the apex in a standard apical 4-chamber window. M-mode is
then used along the plane of the tricuspid annulus, creating a waveform as the
annulus ascends during systole (23) (Figure 1). The TAPSE measurement provides a
quantitative value of the linear displacement of the tricuspid annulus between
systole and diastole. In terms of its relation to RV systolic function, Ghio et al.
determined that TAPSE can be a physiological index of RV function based on RVEF
estimates with thermal dilution and cross-sectional areas methods (27). Kaul et al.
as well as Ueti et al., showed that tricuspid annulus excursion correlated well to
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right ventricular ejection fraction (RVEF), confirmed by radionucleotide
angiography (28,29). Additionally, Ueti et al. showed a significant inverse
correlation between mean pulmonary arterial pressure (MPAP) and RVEF, D wave
integral (DWI), peak velocity of D wave (PVDW) and TAPSE. This was interpreted as
the well-known relation between pulmonary artery pressure and RVEF in
pulmonary, myocardial and valvular heart disease, and results from the dependence
of right ventricular systolic function on afterload (29). Miller et al. also found a
correlation between TAPSE and RVEF, and high specificity and negative predictive
value for detecting abnormal RV systolic function (30). It has also been
demonstrated that TAPSE correlates strongly with RV fractional area change
(RVFAC), log B-type natriuretic peptide, and pulmonary vascular resistance (PVR). A
TAPSE of 17.5 mm was determined to be the best cutoff for detection of RV systolic
dysfunction, defined by RVFAC < 30%, with a sensitivity of 87% and a specificity of
91% (23). Furthermore, its correlation to RVFAC has been proven as a useful
measurement for RV systolic function regardless of pulmonary artery pressures
(31).
However, it should be noted that this still remains an area of contention in
the literature and reproducibility of these correlations, as Anderson et al. showed
little correlation between combining TAPSE in M-mode and tissue Doppler of the
tricuspid annulus (TAPSE-TDI) with RVEF as measured by radionuclide
angiocardiography and gated blood-pool single photon electron computed
tomography, while fractional area change of the RV and RV myocardial performance
index by pulsed-wave Doppler and tissue Doppler correlated well with RVEF (32).
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Moreover, it has been suggested that TAPSE alone is note solely dependent on RV
systolic function, but also on LV systolic function due to tethering and translational
motion of the heart (23). Lopez-Candales et al. concluded that TAPSE < 20 mm is
associated with some degree of either RV or LV dysfunction, and TAPSE > 20 mm
suggests normal biventricular systolic function (33). Finally, it has also been shown
that TAPSE does not correlate well with RVEF in patients with Tetralogy of Fallot
(TOF) (34). Thus, when evaluating right heart strain, low TAPSE values must added
to the entirety of the clinical picture when assessing patients with echocardiography
as it relates to diagnostic and prognostic indications.
Among the numerous conditions known to cause right heart strain, TAPSE
has been used to evaluate congestive heart failure (CHF) (27), MI (35-37),
hypertrophic cardiomyopathy (38), pulmonary hypertension (39-41), postoperatively (42), congenital heart procedures (43), chronic obstructive pulmonary
disease (COPD) (44), and PE (23,45-47). In addition, TAPSE has been shown to have
prognostic value in many of these conditions, including risk stratification and
survival prediction in pulmonary arterial hypertension (PAH) (41,48), heart failure
(25,47), LV systolic dysfunction (50), and ARDS (51).
1.3.2 Prognostic Value of RV Dysfunction in Pulmonary Embolism
RV dysfunction is often evaluated by echocardiography in patients with
suspected PE. It can aid in particular in both the diagnostic workup and prognostic
risk stratification of patients with submassive PE (23,24,45-47,52,53), or massive
PE leading to cardiac arrest and pulseless electrical activity (PEA) (54). RV
dysfunction has been established as a predictor of increased likelihood of death or
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other adverse clinical outcomes from pulmonary embolism (45-47,55). Ribeiro et al.
examined 126 consecutive PE-positive patients with 2D echocardiography. They
divided patients into two groups: those with normal or slightly reduced RV function,
and those with moderately or severely reduced RV function. RV dysfuction was
determined by qualitative evaluation of RV free wall motion, qualitative assessment
of tricuspid regurgitation (TR), and by quantitative determination of the TR jet using
continuous wave Doppler. TR jet analysis was then correlated to right atrial
pressure and pulmonary artery systolic pressure using a simplified Bernoulli
equation. The two predictors of increased likelihood of in-hospital mortality among
the patient population were cancer (hazard ratio of 2.3) and moderate to severe RV
systolic dysfunction (hazard ratio of 6.0). They concluded that 2D echocardiography
can be useful in risk stratification of patients with RV dysfunction and/or history of
malignancy (55).
It has also been shown that point-of-care ultrasound qualitative assessment
of RV strain in patients with acute PE in an Emergency Department setting can have
prognostic indications. In the first study to examine non-cardiologist-performed RV
strain assessment for PE prognosis, Taylor et al. performed a retrospective study of
patients with diagnosed PE and had had point of care ultrasound during their course
of care in the emergency department. They used RV strain qualitative measures of
RV:LV size comparison (≥1), RV wall hypokinesis, and McConnell’s sign, and adverse
clinical outcomes assessed were shock (systolic BP <100 mmHg refractory to
volume loading and requiring vasopressors), respiratory failure requiring
intubation, death, recurrent venous thromboembolism, clinical deterioration as
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evidenced by transition to higher level of care, and major bleeding. It was
determined that RV strain on emergency physician-performed ultrasound was the
single most important prognostic factor in adverse hospital events (Odds Ratio =
9.2) (52).
Quantitative 2D echocardiography measures of RV strain have also been
shown to have prognostic indication for risk-stratification of patients with acute PE.
However, this research has largely been investigated in the field of cardiology. It has
been shown that TAPSE is preferable to RV:LV ratio, and other qualitative measures,
for risk stratification in initially normotensive patients with acute PE (46).
Pruszczyk et al. showed that TAPSE was the only independent predictor of “clinical
end-point” (CE), consisting of 30-day PE-related death or thrombolysis. Moreover,
normotensive patients with a TAPSE ≤ 15 mm had a hazard ratio of 27.9 and a
positive predictive value of 20.9% for CE with a 99% negative predictive value,
while a TAPSE ≤ 20 mm had a positive predictive value of 9.2% for CE with a 100%
negative predictive value. Therefore, patients with a TAPSE ≤ 15 mm can be
identified as high risk for 30 day acute PE-related mortality, while those with a
TAPSE > 20 mm can be identified as a very low-risk group (46).
In the Emergency Department setting, little research has been done to
evaluate the prognostic value of TAPSE performed by emergency physicians.
Zanobetti et al. investigated whether one or more echocardiographic indexes could
predict short-term evolution towards RV dysfunction in patients affected by PE,
with the goal of tailoring therapy in the first hours after diagnosis according to the
hemodynamic profile. They examined sonographic signs of RV dysfunction at the
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time of diagnosis with PE (confirmed by CT), 7 days after diagnosis, and 1 month
after diagnosis, to determine improvement of RV systolic function over time. In the
patient group with low TAPSE (as defined by TAPSE below the mean value of 15
mm), and high pulmonary artery systolic pressure (PASP) (as defined by PASP
above the mean value of 62 mmHg), considerable improvement of RV systolic
function 7 days after diagnosis/treatment only occurred if the patients received
thrombolytic therapy compared to anticoagulation. That is to say, normotensive
patients in that category that received Heparin only did not regain RV systolic
function within one week of diagnosis and treatment. It was concluded that an
intermediate-risk of normotensive patients with depressed TAPSE and elevated
PASP may benefit from thrombolytic therapy after the exclusion of bleeding risk
(47). While this was the first study regarding the assessment of RV dysfunction
using emergency physician-performed echocardiography, the study only examined
the prognostic value of echocardiography indices as they relate to the improvement
of RV function post PE diagnosis and therapy, not as they relate to adverse clinical
outcomes.
1.3.3 Inter-observer Reliability of TAPSE
As previously mentioned, easy and reliable quantitative measures of right
heart strain on bedside echo would be an effective tool for emergency physicians for
risk stratification of patients with PE. Though qualitative measures can be useful,
the inter-observer agreement is not always strong. For example, a retrospective
study of patients presenting to the ED with chest pain, dyspnea, or hypotension,
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who received a limited bedside echo in the ED and a subsequent consultative echo
within 72 hours, showed moderate agreement (κ = 0.44) for RV dilation (53).
TAPSE has been shown to have good inter-observer reliability across a
multitude of cardiac and pulmonary pathologies, including inferior wall MI33,
hypoplastic left heart syndrome54, pulmonary hypertension (41,48), and simply
correlating TAPSE to tricuspid regurgitation (TR) and RVEF (57). In acute PE of
normotensive patients, Kopecna et al. demonstrated that TAPSE had the highest
inter-observer reliability (κ =0.86) compared to other qualitative measures of RV
strain, including that of RV enlargement by diameter (κ = 0.45) and RV enlargement
by RV:LV ratio (κ = 0.65) (45). However, the inter-observer reliability of TAPSE
among emergency physicians has yet to be investigated.
1.4 Electrocardiography in Acute Pulmonary Embolism
1.4.1 Diagnostic and Prognostic Indication: The Daniel Score
While many signs of acute right heart strain can be found with
echocardiography, as previously mentioned, as well as the numerous blood tests
and CT imaging that can be used to aid in the workup of a patient with
undifferentiated dyspnea and suspected PE, there is still a crucial role for
electrocardiography (ECG) in the diagnostic and prognostic evaluation of patients
with acute PE. ECG is one of the first tests performed in the ED and is rapidly
interpretable, low-risk, and inexpensive. When one thinks of the ECG related to PE,
one generally thinks of the “textbook” S1Q3T3. However, S1Q3T3 has been found to
be relatively insensitive for PE and its prevalence has been found in variable rates
among PE positive patients (11% to 52%) (4). Digby et al., reviewed the ECG in the
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setting of PE literature, and found that ECG plays a valuable role for prognostication
for PE (4). ECG abnormalities were found to be reasonable predictors of
hemodynamic decompensation (58), RV dysfunction (59), elevated mean
pulmonary arterial pressure (60), in-hospital complication (61,62), cardiogenic
shock (63), and mortality (64,65).
As previously mentioned, the pathophysiology of PE may lead to ischemic
changes in the right ventricular myocardium due to increased demand. ECG changes
may thus reflect depolarization abnormalities (such as in RBBB), or repolarization
abnormalities (such as in ST segment elevation, depression, or inverted T waves)
(4). ECG abnormalities that may be observed in acute PE, and have been evaluated
in the literature include sinus tachycardia, RBBB, T wave inversions, S1Q3T3, ST
depression (STD), ST elevation (STE), axis deviation, supraventricular tachycardia, P
pulmonale, the QR sign, long QT, QRS fragmentation and Brugada phenocopy (4).
In 2001, Daniel et al. created a comprehensive scoring system for ECG
findings in acute PE (66). The scoring system was as follows (with points awarded
shown in brackets): sinus tachycardia (2), incomplete RBBB (2), complete RBBB (3),
TWI in V1-V4 (0-12 depending on depth), S wave in I (0), Q wave in III (1), TWI in III
(1), S1Q3T3 (2). With 21 being the maximum score, a cutoff of 10 was 23.5%
sensitive and 97.7% specific for the recognition of severe pulmonary hypertension
secondary to PE. They found the derived ECG score increases with the severity of
pulmonary hypertension from PE (66).
Though the Daniel Score provided a comprehensive scoring system for
diagnosing pulmonary hypertension in patients with suspected PE, it did not yield
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prognostic value for the use of risk stratification. Additionally, Digby’s review of the
literature illustrated that findings not included in the Daniel Score, TWIs in nonprecordial leads, STD, STE, the QR sign, QRS fragmentation and atrial fibrillation,
yielded prognostic value for patients with acute PE. In particular, it was shown that
patients with acute PE and right ventricular dysfunction having ischemic ECG
patterns had higher mortality than patients with acute PE and right ventricular
dysfunction without ischemic ECG patterns (67).
1.4.2 Correlating Echocardiography and Electrocardiography: TwiST
With the continued expansion of bedside echo in the ED as a diagnostic and
prognostic exam for patients with suspected PE, the ability to combine laboratory
results, echo findings and ECG findings in risk stratification has dramatically
increased. Thus far, one study has examined correlating echo and ECG findings to
short-term adverse clinical outcomes in an emergency room setting. In particular, a
simplified version of the Daniels Score, the TwiST score, was derived and correlated
to RV strain and adverse clinical outcomes (68). Hariharan et al. defined RV strain
based on echocardiography, CTPA, or biomarker results. Their echocardiography
criteria of RV strain consisted of RV hypokinesis, dilation, and abnormal
interventricular septal movement. They derived a 10-point ECG score (TwiST) for
risk stratification based on modifying the Daniel Score. The scoring system was as
follows (with points awarded shown in brackets): T wave inversions in V1-V3 (5), S
wave in lead I (2), sinus tachycardia (3). Adverse clinical outcomes were measured
after 5 days (68).
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They found that they could effectively risk stratify 85% of patients with acute
PE. A TwiST score of ≤ 2 excluded RV strain with 85% sensitivity whereas a score of
≥ 5 was 93% specific for RV strain in patients with PE. Additionally, the same cut-off
values were 76% sensitive and 87% specific for 5-day adverse clinical events (68). It
should be noted that echoes were performed within 3 days after diagnosis of acute
PE, PE negative counterparts were not enrolled, RV strain identified by
echocardiography only accounted for 35% of confirmed RV strain in the population,
and all echo measurements of RV strain were qualitative in nature. While the study
results provide immense value to the emergency physician, they also provide clear
indication to further investigate the value of expanding the role of bedside
echocardiography in a prospective manor. A quantitative measure of RV strain such
as TAPSE, with known prognostic value, that can be correlated to ECG findings and
adverse clinical events can be an essential tool in risk stratification of patients with
acute PE.
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2. Statement of Purpose
In patients with PE, TAPSE has been shown to correlate strongly with other
echocardiography measurements of RV function. It has also been shown to predict
adverse clinical events. Though the use of TAPSE in assessing patients with
suspected PE has been recently reported in the literature, thus far only one study
has been published regarding its use by emergency medicine physicians (EMPs).
Additionally, no study has analyzed the comparison of electrocardiography scoring
assessments for right heart strain to TAPSE in suspected pulmonary embolism. This
study aims to examine the diagnostic predictability of the use of TAPSE by EMPs in
suspected

PE,

and

the

correlation

of

TAPSE

to

other

established

electrocardiographic predictors of right heart strain. Additionally, this study aims to
investigate the use of these parameters in predicting clinical outcome of patients
with PE.
We hypothesized high Daniels scores (≥10) or high TwiST scores (≥5) would
correlate to having RV systolic dysfunction determined by TAPSE, and that Daniels
scores and Twist scores would be higher, while TAPSE scores would be lower, in PE
positive patients. We also hypothesized that patients who received PE “elevated
care” (PEEC), defined as the need for thrombolysis, pressors, and/or ICU stay ≥1
day, would have higher Daniels scores and TwiST scores, and lower TAPSE
measurements than those who did not.
This study aims to expand the scope of practice for EMPs and provide a
diagnostic tool in evaluating and treating patients presenting with undifferentiated
dyspnea.
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3. Methods
3.1 Design
We performed this study at the emergency department (ED) of Yale-New
Haven Hospital (YNHH), a large, urban, academic hospital that sees more than
80,000 ED visits per year and has an intensive care unit (ICU) admission rate of
approximately 15%. The design of the study was a prospective, blinded,
observational cohort study of adult (age ≥ 18) ED patients with suspected
pulmonary embolism. IRB approval was obtained, and enrollment was
nonconsecutive, and based on convenience of ED research staff. Most patients were
enrolled between the hours of 7 AM and 8 PM during weekdays during the period of
March 2015 to September 2015. Research staff screened patients for who computed
tomography pulmonary angiography (CTPA) was ordered by the attending
physician. Patients were then approached for eligibility and enrollment with
informed consent, and bedside echocardiography was performed as soon as
conveniently possible, without delaying standard patient care.
3.2 Eligibility Criteria
Enrollment criteria included any adult patient for whom CTPA was ordered
and completed for concern of pulmonary embolism. Board certified radiologists
interpreted all radiographic findings as a part of routine clinical care. Patients were
excluded from the study if they were under 18, prisoners, wards of the state, or
unable to provide informed consent.
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3.3 Echocardiography
Subjects underwent transthoracic echocardiography by trained ED providers
using a Phillips Sparq Ultrasound System. Five views were obtained using the
phased array probe and images were recorded. The views obtained were the
parasternal long view, parasternal short view, apical 4 chamber view, subxiphoid
view and an inferior vena cava (IVC) view. The following measures were either
qualitatively or quantitatively recorded: RV dilation (ratio greater than 1:1 with LV),
McConnell’s sign, presence of tricuspid regurgitation (TR), velocity of tricuspid
regurgitation jet, IVC collapsibility and TAPSE. TR jet velocity was determined using
continuous wave Doppler in the apical 4 chamber view. TAPSE was determined
using Motion mode (M-mode) over the tricuspid annulus against the RV free wall.
Total displacement was measured from end-diastole to end-systole, with the
distance being determined by the vertical change from the top of the trough to top
of the peak on the wave form seen in M-mode (figure 1). Low TAPSE was
determined to be ≤ 17mm. Sonographers were blinded to patient CTPA results.
3.4 Electrocardiography
A standard 12-lead ECG was performed in the ED for all but 5 patients
enrolled in the study. ECGs were interpreted by a single, research member, who
trained in interpreting ECGs for 5 months prior to interpreting the ECGs of enrolled
patients in this study. The ECGs were assessed and scored for Daniels Criteria: sinus
tachycardia (2), incomplete RBBB (2), complete RBBB (3), TWI in V1-V4 (0-12
depending on depth), S wave in I (0), Q wave in III (1), TWI in III (1), S1Q3T3 (2), for
a possible total of 21 points. ECGs were also assessed and scored for TwiST Criteria:
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T wave inversions in V1-V3 (5), S wave in lead I (2), sinus tachycardia (3), for a
possible total of 10 points. The ECG reader was blinded to patient outcome and
TAPSE measurement while reviewing and scoring ECGs. Figure 2 shows an example
of a patient who was PE positive and had high Daniels and TwiST scores of 20 and
10 respectively.
3.5 Prognostic Evaluation: PE Elevated Care (PEEC)
Patients diagnosed with pulmonary embolism were followed for up to 30
days as inpatients and using death registries to determine any association between
findings on ECG and bedside echo to morbidity, mortality, and level of care required.
These included factors such as disposition (ICU, step-down unit, floor), requirement
of pressors, requirement of thrombolysis, length of stay and mortality. In addition,
we stratified patients with these indicators into PE positive patients that required
PE Elevated Care (PEEC), defined as the need for thrombolysis, pressors, and/or ICU
stay ≥1 day, and patients who did not require PEEC.
3.6 Statistical Analysis
3.6.1 Diagnosis of PE
Diagnostic characteristics of sensitivity, specificity, positive likelihood ratio,
negative likelihood ratio, and positive and negative predictive values, were
determined for diagnosing patients with PE using the Daniels score, TwiST score,
and 2 different TAPSE values. One TAPSE value of 17 mm was used for higher
specificity, and a value of 21 mm was used for higher sensitivity. Statistical analyses
were calculated using the online software VassarStats (vassarstats.net).
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3.6.2 Comparison of TAPSE and ECG
Diagnostic characteristics of sensitivity, specificity, positive likelihood ratio,
negative likelihood ratio, and positive and negative predictive values were
determined for the Daniels and TwiST scores ability to diagnose right heart strain as
determined by a “low TAPSE” of ≤17 mm. Statistical analyses were calculated using
the online software VassarStats (vassarstats.net).
Additionally, patients were stratified into “low TAPSE” and “normal TAPSE” groups.
Mean ECG scores for the Daniels and TwiST criteria were compared between groups
using student’s t-test. Patients were also stratified into PE positive and PE negative
groups. Mean TAPSE measurements, and Daniels score and TwiST scores were
compared between groups using student’s t-test. Statistical analyses were calculated
using the online software VassarStats (vassarstats.net).
3.6.3 TAPSE, ECG and PEEC
Mean TAPSE, Daniels and TwiST scores and relative risks were calculated for
patients who received “elevated care” compared to those who did not. The relative
risk of low TAPSE (≤17 mm) and high Daniels (≥10) and TwiST (≥5) for elevated
care were also compared. Statistical analyses were calculated using the online
software VassarStats (vassarstats.net).
3.6.4 The Role of Research Study Members
In regards to the methods described above, I enrolled 90 of the 110 patients
in the research study and performed their echocardiogram in the emergency
department. Additionally, I interpreted all of the ECGs for the study population as
well as performed all statistical analyses. Patients were also enrolled by Dr. James
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Daley, Dr. Michael Kennedy Hall, Dr. Joseph Pare, Dr. Rachel Liu, Dr. Andrew Taylor
and Dr. Chris Moore.
4. Results
4.1 Enrollment Demographics and Hospital Course
We enrolled 110 patients in total, 45 men and 65 women, and 23 patients
were diagnosed with a pulmonary embolism (PE positive). Of the 23 patients with
PE, 13 were men and 10 were women. Of the 110 patients enrolled, 105 had
recorded ECG’s, and all underwent bedside echocardiography. Enrolled patients
ranged from 18 to 90 years old, with an average age of 58.6 (SD±17.4) years old. PE
positive patients had an average age of 63.4 (SD±15.1) years old, while PE negative
patients had an average age of 57.4 (SD±17.9) years old. 23 patients were
discharged from the Emergency Department (1 who was PE positive), 30 patients
were admitted to the floor (13 who were PE positive) and 24 were admitted to
either the step down unit (SDU) or intensive care unit (ICU) (9 who were PE
positive) (Table 1). Other dispositions of patients that were not tracked include
telemetry observation and admission to the chest pain center. The mean length of
stay for enrolled patients was 3.9 (SD±5.4) days. The mean length of stay for PE
positive patients was 6.7 (SD±6) days, while the mean length of stay for PE negative
patients was 3.3 (SD±5.1) days (Table 1).
4.2 Diagnosis of PE
When total Daniels score was evaluated for the ability to diagnose PE, we
first began with the ability of a low Daniels score (≤2) to rule out a PE, that is, the
ability to “diagnose” PE negative. A Daniels score of ≤2 was 58% (95% CI, 46%-
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58%) sensitive and 50% (95% CI, 28%-72%) specific for determining PE negative
patients. In addition, it had a positive likelihood ratio of 1.2, a negative likelihood
ratio of 0.87, a positive predictive value of 83% and a negative predictive value of
22% (Table 2). Then, the ability of the Daniels score to predict PE was evaluated in
an increasing fashion, beginning with Daniels score of ≥3, followed by cutoffs of 7,
10, 12 and 17. Sensitivities decreased from 50% (95% CI 28%-72%) to 13% (95%
CI 2%-42%) among these groups, while specificities increased from 58% (95% CI
46%-68%) to 99% (95% CI 93%-100%) (Table 2). Positive likelihood ratios
increased from 1.2 (0.7-1.95) to 12 (1.2-124), while negative likelihood ratios
showed varying ranges among cutoff values (Table 2). Positive predictive values
increased from 22% (11%-37%) to 67% (13%-98%) and negative predictive values
increased from 83% (71%-91%) to 87% (79%-93%) (Table 2).
When total TwiST score was evaluated for the ability to diagnose PE, similar
to with the Daniels score, we first began with the ability of a low TwiST score (≤2) to
rule out a PE, that is, the ability to “diagnose” PE negative. A TwiST score of ≤2 was
63% (95% CI, 52%-73%) sensitive and 50% (95% CI, 27%-73%) specific for
determining PE negative patients. In addition, it had a positive likelihood ratio of
1.4, a negative likelihood ratio of 0.79, a positive predictive value of 86% and a
negative predictive value of 22% (Table 3). The ability of the TwiST score to predict
PE was evaluated in an increasing fashion, beginning with TwiST score of ≥3,
followed by cutoffs of 5, 7, and 8. Sensitivities decreased from 50% (95% CI 27%73%) to 29% (95% CI 12%-52%) among these groups, while specificities increased
from 63% (95% CI 52%-73%) to 93% (95% CI 85%-97%) (Table 3). Positive
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likelihood ratios increased from 1.4 (0.8-2.3) to 4 (1.4-11), while negative likelihood
ratios showed varying ranges among cutoff values (Table 3). Positive predictive
values increased from 22% (11%-38%) to 50% (22%-78%) and negative predictive
values decreased from 86% (74%-93%) to 84% (74%-90%) (Table 3).
With regard to the ability of TAPSE to diagnose PE, TAPSE values ≤ 17 mm
were 57% (95% CI 34%-77%) sensitive and 87% (95% CI 78%-93%) specific in
diagnosing PE (Table 4). Additionally, the cutoff of ≤ 17 mm had a positive
likelihood ratio of 4.3 (2.2-8.3) and a negative likelihood ratio of 0.5 (0.3-0.8), as
well as a positive predictive value of 54% (33%-74%) and a negative predictive
value of 88% (79%-94%). TAPSE values ≤ 21 mm were 79% (95% CI 57%-92%)
sensitive and 67% (95% CI 55%-76%) specific in diagnosing PE. Additionally, the
cutoff of ≤ 21 mm had a positive likelihood ratio of 2.4 (1.6-3.4) and a negative
likelihood ratio of 0.31 (0.14-0.69), as well as a positive predictive value of 40%
(27%-56%) and a negative predictive value of 92% (81%-97%) (Table 4).
4.3 Comparison of ECG Scoring and TAPSE Measurements
In evaluating a correlation between higher Daniels and TwiST scores and
lower TAPSE scores, the ability of Daniels and TwiST scores to “diagnose” a low
TAPSE (≤17 mm) was determined. Similarly, in the evaluation of diagnosing PE, a
Daniels score of ≤2 was evaluated to rule out a low TAPSE. A Daniels score of ≤2 was
60% (95% CI, 48%-71%) sensitive and 77% (95% CI, 55%-92%) specific for
determining high TAPSE patients. In addition, it had a positive likelihood ratio of
2.64, a negative likelihood ratio of 0.5, a positive predictive value of 91% and a
negative predictive value of 35% (Table 5). Then, the ability of the Daniels score to
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predict low TAPSE was evaluated in an increasing fashion, beginning with Daniels
score of ≥3, followed by cutoffs of 7, 10, 12 and 17. Sensitivities decreased from 77%
(95% CI 55%-92%) to 13% (95% CI 3%-34%) among these groups, while
specificities increased from 60% (95% CI 48%-71%) to 100% (95% CI 95%-100%)
(Table 5). Positive likelihood ratios increased from 2.64 (1.2-5.8) to 17 (2-140),
while negative likelihood ratios showed varying ranges among cutoff values (Table
5). Positive predictive values increased from 35% (22%-50%) to 100% (29%100%) and negative predictive values decreased from 91% (71%-97%) to 80%
(70%-87%) (Table 5).
A TwiST score of ≤2 was 70% (95% CI, 68%-79%) sensitive and 87% (95%
CI, 66%-97%) specific for determining high TAPSE patients. In addition, it had a
positive likelihood ratio of 5.34, a negative likelihood ratio of 0.35, a positive
predictive value of 95% and a negative predictive value of 45% (Table 6). The
ability of the TwiST score to predict low TAPSE was also evaluated in an increasing
fashion, beginning with a TwiST score of ≥3, followed by cutoffs of 5, 7, and 8.
Sensitivities decreased from 70% (95% CI 68%-79%) to 39% (95% CI 20%-61%)
among these groups, while specificities increased from 70% (95% CI 68%-79%) to
96% (95% CI 89%-99%) (Table 6). Positive likelihood ratios increased from 5.34
(2-15) to 10.3 (3-35), while negative likelihood ratios showed varying ranges among
cutoff values (table 6). Positive predictive values increased from 45% (30%-62%) to
75% (43%-95%) and negative predictive values decreased from 95% (86%-99%) to
84% (75%-91%) (Table 6).
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Patients with low TAPSE had a mean Daniels score of 7.26 (SD±5.9) while
patients with a TAPSE > 17 mm had a mean Daniels score of 2.5 (SD±2.5). Patients
with low TAPSE had a mean TwiST score of 5.52 (SD±3.3) while patients with a
TAPSE > 17 mm had a mean TwiST score of 1.79 (SD±2.4). Mean Daniels scores and
TwiST scores were significantly different between low and high TAPSE groups
(p<0.0001), and high Daniels and TwiST scores correlated to low TAPSE (p<0.0001
and p=0.0002 respectively). PE positive (PE+) patients had a significantly lower
mean TAPSE value of 17.6 mm (SD±5.0) compared to 22.2 mm (SD±5.3) in PE
negative (PE-) patients (p=0.0003). PE+ patients had a significantly higher mean
Daniels score of 5.95 (SD±6.05) compared to 2.96 (SD±3.24) in PE- patients
(p=0.0024). PE+ patients had a significantly higher TwiST score of 4.38 (SD±3.46)
compared to 2.24 (SD±2.77) in PE- patients (p=0.0033) (Table 7).
4.4 PEEC v. Non-PEEC
Mean TAPSE for patients requiring PEEC was 15.2 mm (SD±5.07) compared
to 19.4 mm (SD±4.27) for those who did not (p=0.047). Mean Daniels score for
patients requiring PEEC was 8.2 (SD±5.4) compared to 3.9 (SD±6.1) for those who
did not (p=0.11). Mean TwiST for patients requiring PEEC was 6.6 (SD±3.5)
compared to 3.0 (SD±2.96) for those who did not (p=0.020). TAPSE ≤17 mm,
Daniels ≥10, and TwiST ≥5 had increased risks of 6.9 (p=0.045), 2.0 (p=0.11) and 4.4
(p=0.025) respectively for requiring PEEC (Table 8).
5. Discussion
In the context of using echocardiography and electrocardiography to aid in
the diagnosis of PE in suspected patients, it was found that high Daniels and TwiST
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scores were specific for diagnosing PE in this patient population. A Daniels score
≥10 and a TwiST score ≥7 were 94% and 90% specific for PE respectively. Though
this study had a relatively small enrollment, and specifically, a small number of PE
positive patients, the trends in increasing specificity with increasing TwiST and
Daniels score may relate to their ability to detect right heart strain in PE positive
patients. This finding correlates well with the prior literature regarding the Daniels
and TwiST scores. As Daniels found that an increase in his derived ECG score
corresponded to increasing severity of pulmonary hypertension from PE (66), and
Hariharan et al. showed that the TwiST score effectively risk stratified 85% of
patients with acute PE (68), it is reasonable to conclude that higher Daniels scores
and TwiST scores in a patient population with suspected pulmonary embolism
would aid in detection of RHS in those with acute pulmonary embolism.
When analyzing the utility of TAPSE in diagnosing PE, the cutoff of 17 mm
yielded a higher specificity for PE, however the sensitivity was low. The sensitivity
was increased to 79% when 21 mm was used as a cutoff, however this decreased
the specificity to 67%. This may be indicative of the utility of differing ranges of
TAPSE values that likely correspond to the degree of RHS. It may be useful to have
separate cutoff values as seen in this study to maximize sensitivity and specificity.
That is, a TAPSE less than 17 mm may be useful for ruling in PE, while a TAPSE
greater than 21 mm may be useful at ruling out PE. An “intermediate zone” between
17 and 21 mm may exist in which clinical judgement and further testing would be
useful. That said, this study only examined those cutoffs at 17 mm and 21 mm.
Further research with a larger population would be beneficial in order to determine
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the best values to optimize sensitivity and specificity in diagnosing PE in patients
with suspected PE. These cutoff values, however, are consistent with prior literature
in the use of TAPSE as a diagnostic tool for RV dysfunction. An optimal cutoff for
diagnosing RV dysfunction using TAPSE has been suggested to be < 17.5 mm (31),
while an optimal cutoff for concluding normal biventricular function has been
suggested to be > 20 mm (33).
When stratifying PE positive and PE negative patients, it was determined that
PE positive patients had significantly lower TAPSE measurements, as well as
significantly higher Daniels and TwiST scores. It should be emphasized that the
patients in this study were all suspected of having a PE to the point at which the
attending physician ordered a CTA/PE protocol. Thus, it is important to keep in
mind that these diagnostic tools certainly cannot make a diagnosis of PE alone, but
rather can be used in the context of a patient with suspected PE to rule in or out
evidence of right heart strain. This is to say, among any patient, these tools likely
have low sensitivity and specificity for diagnosing PE, but are likely useful in
diagnosing right heart strain. In a patient with evidence of right heart strain either
by Daniels score or TwiST score, by TAPSE measurement, or by some combination,
for whom PE is on the differential, these tools may help aid in the work up or
diagnosis of PE.
Additionally, it was shown that increasing Daniels and TwiST scores
correlate well to RHS as defined by low TAPSE. When correlating Daniels and TwiST
scores to measured TAPSE values, lower Daniels and TwiST scores had higher
sensitivities of ruling out a low TAPSE while higher Daniels and TwiST scores were
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more specific for ruling in a low TAPSE. Though this was expected as all of these
modalities have been linked to right heart strain, it was encouraging to find that
trends existed, as TAPSE is more a measure of dynamic function than what may
conventionally be used to diagnose right heart strain (RV>LV on CT or echo).
Additionally, it appears as though the TwiST score provided better sensitivity and
the Daniels score provided better specificity in diagnosing RV dysfunction as
indicated by low TAPSE. This is likely due to the nature of the two scoring systems,
with the Daniels score being far more comprehensive than the TwiST. With only 3
items, it seems the TwiST score has the most pertinent elements to rule out right
heart strain, that is, tachycardia, strain on the RV conduction system as evidenced by
an S wave in lead I, and ischemic changes as evidenced by T-wave inversion in
precordial leads V1-V3. A TwiST score <3 was 87% sensitive in ruling out a low
TAPSE compared to 77% using the Daniels score. With regard to specificity, due to
the comprehensiveness of the Daniels score, it had increased specificity for ruling in
low TAPSE values. Both a Daniels score of ≥10, and a TwiST score of ≥8 had
specificities of 96%. However, because the Daniels score is more inclusive and has
many different iterations of point totals, specificity was able to be increased to 99%
and 100% for scores ≥12 and ≥17 respectively. When stratifying patients into low
TAPSE values (≤17 mm) and high TAPSE values, patients with low TAPSE values had
significantly higher mean Daniels and TwiST scores. This finding corroborates the
value of TAPSE as a marker for RV systolic function, as well as the ECG scoring
criteria as being predictive of RV strain. Moreover, we found additional
corroboration with mean Daniels and TwiST scores when stratifying patients into
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low and high TAPSE groups, and then PE positive and PE negative groups. Mean
Daniels and TwiST scores were significantly higher in the low TAPSE group, and
significantly higher in the PE positive group. Additionally, mean TAPSE values were
significantly lower in the PE positive group compared to the PE negative group.
Again, this highlights the utility of ECG scoring and TAPSE in detecting RHS noninvasively. This intuitively makes sense for patients with suspected PE in that in
order to have a suspicion of PE as a diagnosis, the patients are likely symptomatic.
The clot burden that produces such symptoms is also responsible for the effect on
resistance in the pulmonary circulation. In turn, increased right sided pressures
along with supply/demand mismatch likely has a correlating effect on the
conduction system. This combination of factors would explain the correlation of PE
and RHS with the ECG and echo findings. While this may not be diagnostically useful,
it helps illustrate the pathophysiology of PE, and the associated effects on
hemodynamics and cardiac conduction and contractility, in particular with the right
ventricle.
The findings surrounding prognosis of PE positive patients with regard to the
level of care required also seems to correlate with the degree to which the clot
affected RV function as determined by TAPSE or ECG scores. Patients requiring
“elevated care” had significantly lower TAPSE and significantly higher TwiST. In
addition, patients with low TAPSE and TwiST ≥5 had significantly increased relative
risk of requiring “elevated care.” Physiologically, this makes sense, as these patients
have evidence of increased hemodynamic compromise, and it has already been
shown that RV dysfunction in PE predicts in-hospital mortality (55). This suggests
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that those two point-of-care tests have prognostic value in PE care. However,
patient disposition may be subjective, and hospital length of stays often include
complications unrelated to the admitting diagnosis. One of the limitations of this
study is that more information was not gathered regarding the hospital course of PE
positive patients. Additionally, there was no follow up done with regard to long term
sequelae or morbidity/mortality and any association with lower TAPSE or high
Daniels or TwiST scores on initial presentation. These limitations certainly have
implications regarding the findings of this study and their internal validity. We
cannot say with certainty that all cases of patients requiring longer hospital stays
were directly related to acute pulmonary embolism. Additionally, though we may be
able to comment on the short term prognosis and level of care regarding these
patients, without long term follow up, we cannot comment on how risk stratification
and treatment may affect long term morbidity and mortality.
In conclusion, the results of this study demonstrate a link between TAPSE
and ECG scores as determined by the Daniels and TwiST criteria, with RHS being the
likely common denominator. Though this may seem inherent based on previous
research, this still may provide utility. Hospital resources often differ, and TAPSE is
not a measurement that is often taken during bedside echo in emergency
departments. Having an understanding that there is a correlation between ECG
scoring and TAPSE values will allow practitioners to potentially use either, or both,
in evaluating a patient with suspected PE. Additionally, there was correlation with
the level of care required, again with RHS/RV dysfunction being the likely common
denominator. This is consistent with prognostic data in prior studies, and bedside
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echo and/or ECG scoring systems can provide physicians additional information to
risk stratify patients with submassive PE who may require a higher level of
inpatient care. Of course, this particular study was limited by many factors, notably
the small sample and small number of PE positive patients, as well as the fact that it
was a convenience sample as opposed to consecutive enrollment, which may have
affected the study’s internal validity. Additionally, limited data was acquired with
regard to patients after their admission to the hospital. Further research would be
helpful in further determining the role of using TAPSE and/or the Daniels or TwiST
score in diagnosing and prognosticating patients with acute PE. Thus far these
modalities have shown to correlate well with RHS, and suggest to have utility in
diagnosing PE in a symptomatic patient in which PE is suspected, but comfirmatory
studies with larger sample sizes would provide more optimal cutoff ranges in
adding to the current tools for PE diagnosis and prognosis.
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6. Figures
Figure 1: TAPSE measurement using M-mode over the tricuspid annulus.
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Figure 2: 12-lead ECG tracing of a PE positive patient with a Daniels score of 20 and
TwiST score of 10. (Daniels: tachycardia (2), incomplete RBBB (2), TWI V1-V4 (4),
TWI in V1 >2mm (2), TWI in V2 >2 mm (3), TWI in V3 >2mm (3), Q III (1), TWI III
(1), SIQIIITIII (2)) (TwiST: TWI V1-V3 (5), SI (2), tachycardia (3))

7. Tables
Table 1: Demographics, dispositions and length of stays for enrolled patients.
All Subjects (n=110)

PE + (n=23)

PE- (n=87)

Age (±SD)

58.6 (±17.4)

63.4 (±15.1)

57.4 (±17.9)

Male (%)

45 (41)

13 (56.5)

32 (36.8)

Female (%)

65 (59)

10 (43.5)

55 (63.2)

Discharged (%)

23 (21)

1 (4.3)

22 (25.2)

Admit to Floor (%)

30 (27)

13 (56.5)

27 (31)

Admit to SDU/ICU

24 (21.8)

9 (39.1)

15 (17)

Length of Stay (±SD)

3.9 (5.4)

6.7 (6)

3.3 (5.1)
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Table 2: Diagnostic characteristics of Daniels scores in diagnosing PE.
Daniels

N(%)

Score

≤ 2 PE-

59

Sensitivity,

Specificity,

Positive

Negative

PPV, %

NPV, %

%

%

Likelihood

Likelihood

(95% CI)

(95% CI)

(95% CI)

(95% CI)

58 (46-58)

50 (28-72)

1.2

0.87

83

22

(0.7-1.95)

(0.55-1.37)

(71-91)

(11-37)

1.2

0.87

22

83

(0.7-1.95)

(0.55-1.37)

(11-37)

(71-91)

3.8

0.67

47

86

(1.7-8.6)

(0.47-0.96)

(24-71)

(77-92)

5.6 (2-16)

0.7

58

85

(0.5-1)

(23-85)

(76-92)

(56)
≥3

46

50 (28-72)

58 (46-68)

(44)
≥7

17

40 (20-64)

89 (80-95)

(16)
≥10

12

33 (15-57)

94 (78-98)

(11)
≥12

≥17

6 (6)

3 (3)

24 (8-50)

13 (2-42)

98

10.4

0.78

67

87

(91-100)

(2-52)

(0.6-1.0)

(24-94)

(78-93)

99

12

0.88

67

87

(93-100)

(1.2-124)

(0.72-1.1)

(13-98)

(79-93)

49
Table 3: Diagnostic characteristics of TwiST scores in diagnosing PE.
TwiST

N(%)

Score

≤ 2 PE-

64

Sensitivity,

Specificity,

Positive

Negative

PPV, %

NPV, %

%

%

Likelihood

Likelihood

(95% CI)

(95% CI)

(95% CI)

(95% CI)

63 (52-73)

50 (27-73)

1.4

0.79

86

22

(0.8-2.3)

(0.49-1.3)

(74-93)

(11-38)

1.4

0.79

22

86

(0.8-2.3)

(0.49-1.3)

(11-38)

(74-93)

3.3

0.66

45

86

(1.6-6.9)

(0.45-1)

(23-68)

(77-92)

3.5

0.74

47

84

(1.4-8.6)

(0.54-1.0)

(22-73)

(75-91)

4

0.77

50

84

(1.4-11)

(0.59-1.0)

(22-78)

(74-90)

(61)
≥3

41

50 (27-73)

63 (52-73)

(39)
≥5

20

43 (23-66)

87 (78-93)

(19)
≥7

15

33 (15-57)

90 (82-96)

(14)
≥8

12

29 (12-52)

93 (85-97)

(11)

Table 4: Diagnostic characteristics of TAPSE values in diagnosing PE.
TAPSE

N(%)

(mm)

TAPSE

24

(17)

(22)

TAPSE

47

(21)

(44)

Sensitivity,

Specificity,

Positive

Negative

PPV, %

NPV, %

%

%

Likelihood

Likelihood

(95%

(95% CI)

(95% CI)

(95% CI)

57 (34-77)

87 (78-93)

79 (57-92)

67 (55-76)

CI)
4.3

0.5

54

88

(2.2-8.3)

(0.3-0.8)

(33-74)

(79-94)

2.4

0.31

40

92

(1.6-3.4)

(0.14-0.69)

(27-56)

(81-97)
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Table 5: Diagnostic characteristics of Daniels scores in diagnosing right heart strain
as determined by “low TAPSE.”
Daniels

N(%)

Score

≤2

53

high

(52)

Sensitivity

Specificity,

Positive

Negative

PPV, %

NPV, %

%

% (95%

Likelihood

Likelihood

(95% CI)

(95% CI)

(95% CI)

CI)

60 (48-71)

77 (55-92)

2.64

0.5

91

35

(1.2-5.8)

(0.4-0.7)

(79-97)

(22-50)

2.64

0.5

35

91

(1.2-5.8)

(0.4-0.7)

(22-50)

(79-97)

6.54

0.6

65

86

(3-16)

(0.4-0.8)

(38-86)

(77-92)

12.6

0.6

77

87

(4-42)

(0.4-0.8)

(46-95)

(78-93)

17 (2-140)

0.8 (0.6-1)

83

81

(36-100)

(72-88)

0.9

100

80

(0.7-1.0)

(29-100)

(70-87)

TAPSE
≥3

49

77 (55-92)

60 (48-71)

(48)
≥7

≥10

16(16)

17

48 (27-69)

45 (24-68)

92 (84-97)

96 (89-99)

(17)
≥12

6 (6)

22 (7-44)

99
(93-100)

≥17

3 (3)

13 (3-34)

100
(95-100)

-------------
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Table 6: Diagnostic characteristics of TwiST scores in diagnosing right heart strain
as determined by “low TAPSE.”
TwiST

N(%)

Score

≤ 2 high

58

TAPSE

(57)

≥3

44

Sensitivity,

Specificity,

Positive

Negative

PPV, %

NPV, %

%

%

Likelihood

Likelihood

(95% CI)

(95% CI)

(95% CI)

(95% CI)

70 (68-79)

87 (66-97)

5.34

0.35

95

45

(2-15)

(0.24-0.51)

(86-99)

(30-61)

5.34

0.35

45

95

(2-15)

(0.24-0.51)

(30-61)

(86-99)

3.9

0.48

52

88

(2.1-7.37)

(0.29-0.8)

(31-72)

(79-95)

7.27

0.58

67

86

(3-19)

(0.4-0.86)

(38-88)

(77-93)

10.3

0.63

75

84

(3-35)

(0.45-0.88)

(43-95)

(75-91)

87 (66-97)

70 (68-79)

(43)
≥5

25

59 (36-79)

85 (75-92)

(25)
≥7

15

45 (24-68)

94 (86-98)

(15)
≥8

12
(12)

39 (20-61)

96 (89-99)

52
Table 7: Differences in mean ECG scores for low vs. high TAPSE and PE positive vs.
PE negative patients.
Daniels

TwiST

TAPSE ≤17 mm Mean (±SD)

7.2 (±5.9)

5.5 (±3.3)

TAPSE > 7mm Mean (±SD)

2.5 (±2.5)

1.8 (±2.4)

Difference (95% CI)

4.7 (3.1-6.4)

3.7 (2.5-5)

Level of significance

p<0.0001

p<0.0001

Daniels

TwiST

TAPSE

PE + Mean (±SD)

5.9 (±6.1)

4.4 (±3.4)

17 mm (±5.0)

PE - Mean (±SD)

2.9 (±3.2)

2.2 (±2.7)

22 mm (±5.3)

Difference (95% CI)

3.0 (1.1-4.9)

2.1 (0.73-3.5)

4.6 (2.2-7.1)

Level of significance

p = 0.0024

p = 0.0033

p = 0.0003

Table 8: Mean TAPSE and ECG scores for PEEC vs. non-PEEC patients, and relative
risk of PEEC.
TAPSE

Daniels

TwiST

PEEC Mean (±SD)

15 mm (5.1)

8.2 (5.4)

6.6 (3.5)

Non-PEEC Mean (±SD)

19 mm (4.2)

3.9 (6.1)

3.0 (2.9)

Difference (95% CI)

4.1 (0-8.2)

4.3 (-1.0 to 9.6)

3.6 (0.64-0.65)

Level of significance

p = 0.047

p = 0.11

p = 0.020

TAPSE ≤17 mm

Daniels ≥10

TwiST ≥5

6.9

2.0

4.4

95% CI

1-46

0.86-4.6

1.2-16

Level of significance

p = 0.045

p = 0.11

p = 0.025

Relative Risk of
elevated care

